- 2021 news releases
- 2020 news releases
- 2019 news releases
- 2018 news releases
- 2017 news releases
- 2016 news releases
Marquette University Fast Facts
PROBLEM WITH THIS WEBPAGE?
To report another problem, please contact email@example.com.
February 28, 2018
MILWAUKEE — Rebecca Eisenberg, a professor at the University of Michigan Law School, will present "Opting for Regulation When Patentability Is in Doubt" for Marquette Law School's Nies Lecture in Intellectual Property on Tuesday, March 6, at 4:30 p.m. in Eckstein Hall's Lubar Center.
Eisenberg specializes in intellectual property and the regulation of biopharmaceutical innovation. In this lecture, she will examine the complex strategic considerations that innovators face in navigating the intersection of patents, regulatory approval and insurance coverage for new health-related technologies.
One example of this can be found in new technologies that have dramatically reduced the cost of DNA sequencing, making it feasible to use genetic testing to select the most appropriate treatment for each patient. Recent judicial decisions have cast doubt on the patentability of the DNA sequences and interpretive algorithms that make up these new diagnostic tests, threatening to undermine investment incentives for this promising field of research. On the other hand, the U.S. Food and Drug Administration has so far allowed most laboratory-developed diagnostic tests to be sold without regulatory approval. Perhaps by avoiding this regulatory burden, test developers can survive without patents. Surprisingly, however, some test developers are forgoing this regulatory break and instead opting to pursue approval that the FDA does not require.
Eisenberg's teaching includes courses about patent law, trademark law, international intellectual property law and FDA law. She has written and lectured extensively about the role of intellectual property in biopharmaceutical research, publishing in leading law reviews and scientific journals. Eisenberg also has played an active role in public policy debates concerning the role of intellectual property in biopharmaceutical research, advising the National Institutes of Health and the National Academies of Science. She is a graduate of Stanford University and Boalt Hall School of Law at the University of California, Berkeley. In 1984, Professor Eisenberg joined the faculty at the University of Michigan, where she serves as the Robert & Barbara Luciano Professor of Law.
Seating is available; registration is required and is available online. Members of the media who are interested in attending should contact Chris Jenkins in the Office of Marketing and Communication.